Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BIIB061 in Healthy Volunteers
NCT02228707Phase 1Completed
- Sponsor
- Biogen
- Start
- Aug 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in multiple sclerosis (MS) comparing BIIB061 with Placebo (2 arms). Primary endpoint: Number of participants experiencing Adverse Events. Started Aug 2014; status: completed.
02
Drugs
BIIB061
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02228707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02228707.